AN
52
-2
DLTR
36
2
WY
53
-3
WMB
70
-2
HRL
33
4
ACN
65
16
AIZ
75
2
CNX
75
-5
DE
38
-4
SLG
66
-7
FOXA
67
3
SNA
75
3
MMC
65
3
DNB
86
-2
SHW
68
-5
ADBE
55
6
RL
76
-3
TSN
47
9
AEP
45
-2
MSFT
57
4
AN
52
-2
DLTR
36
2
WY
53
-3
WMB
70
-2
HRL
33
4
ACN
65
16
AIZ
75
2
CNX
75
-5
DE
38
-4
SLG
66
-7
FOXA
67
3
SNA
75
3
MMC
65
3
DNB
86
-2
SHW
68
-5
ADBE
55
6
RL
76
-3
TSN
47
9
AEP
45
-2
MSFT
57
4
Financhill
Back

Protagonist Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison

Sell
32

PTGX
Protagonist Therapeutics

Last Price:
42.64
Seasonality Move:
12.96%
Buy
79

TRDA
Entrada Therapeutics

Last Price:
19.97
Seasonality Move:
-35.78%
Sell
32
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $43.19. The Score for PTGX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $19.79. The Score for TRDA is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $43.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $19.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 37.41 Sell
Chaikin Money Flow: -566040 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.97 - 47.71) Sell
Bollinger Bands (100): (36.87 - 46.33) Buy

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 75.02 Buy
Chaikin Money Flow: 113940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.57 - 18.73) Buy
Bollinger Bands (100): (14.77 - 17.59) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.32 Sell
20-day SMA: 46.77 Sell
50-day SMA: 45.53 Sell
200-day SMA: 35.17 Buy
8-day EMA: 45.98 Sell
20-day EMA: 46.24 Sell
50-day EMA: 44.92 Sell
200-day EMA: 36.49 Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.92 Buy
20-day SMA: 17.91 Buy
50-day SMA: 16.49 Buy
200-day SMA: 15.06 Buy
8-day EMA: 19.05 Buy
20-day EMA: 18.11 Buy
50-day EMA: 17.08 Buy
200-day EMA: 15.67 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):